Foundation Bundle

Best-in-class: Foundation Bundle

Thorne's foundation bundle -- separate products boxed together rather than one formula, sold as a daily base. Thorne sets what ships in the box and can change it without notice, so this page does not enumerate the contents.

How Foundation Bundle actually works

The four to six nutrients where deficiency is common and consequences are real — vitamin D, magnesium, omega-3 and usually a multivitamin base. Each has an independent mechanism; the bundle premise is that these are the gaps most likely to exist and most likely to blunt everything else.

Where to get Foundation Bundle

The evidence for Foundation Bundle

Graded by what exists behind each claim.

✅ Clinically validated

• Boxes daily essentials together so the highest-impact bases are bought in one go; which products are in the box is the vendor's decision, not a formula.

📊 Correlative data

• A bundle has no epidemiology of its own. Where observational evidence exists it belongs to the individual ingredients and sits on their pages — read it there rather than inferring it for the combination, which nobody has studied as a unit.

🧪 Theoretical / extrapolated benefits

• No bundle has been studied as a unit, so any claim about the combination is extrapolated from the individual components. Where two ingredients share a pathway, additivity is plausible; where they do not, expect independence. Read each component's own page for what is actually predicted of it.

How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →

What Foundation Bundle actually does

Start with the honest structural fact, because it shapes everything below: of the ten products in this category, this one's entry in the site's own catalog names no ingredient at all. The description reads core micronutrients and the dose field reads as directed. So this page cannot tell you what is in the box. What it can do is tell you what a foundation product is doing when it works, which turns out to be a narrower and more interesting thing than the category implies.

A micronutrient is not a drug and does not have a dose-response. It is an enzyme cofactor, and enzymes obey saturation kinetics. Thiamine becomes thiamine pyrophosphate for pyruvate dehydrogenase and transketolase. Riboflavin becomes FAD for succinate dehydrogenase in the respiratory chain. Pyridoxine becomes pyridoxal-5-phosphate for well over a hundred transaminases and decarboxylases. In every one of those cases, once the cofactor concentration is comfortably above the enzyme's binding constant, the enzyme is running at its maximum rate and additional cofactor changes nothing. That is the mechanism of a multivitamin: it can fill an empty seat and it cannot make a full seat fuller. No competitor page states this, because it is the sentence that explains why the product usually does nothing.

Two exceptions where the pharmacology is real. Vitamin D is not a cofactor — it is a secosteroid hormone precursor whose active form binds the vitamin D receptor, a nuclear transcription factor that heterodimerizes with RXR and changes the expression of hundreds of genes. Dose therefore matters in a way it does not for thiamine. Magnesium is the other: the physiological substrate of every kinase and every ATPase is not ATP but the Mg-ATP complex, so magnesium is consumed by the reaction rather than merely permitting it.

And here is where two ingredients in this box act on the same step. Vitamin D has to be hydroxylated twice before it does anything — by CYP2R1 in the liver to 25-hydroxyvitamin D, then by CYP27B1 in the kidney to the active hormone. Both hydroxylases are magnesium-dependent, as is the vitamin D binding protein that carries the metabolites. So the magnesium arm of a foundation bundle gates the activation of its own vitamin D arm. That is the one genuine internal dependency in a general micronutrient product, it predicts that a magnesium-depleted person converts their vitamin D poorly, and it is the argument for these two being in the same box rather than the same aisle.

Cell, rodent, human — and where it stops

Vitamin D: the dose-response curve exists, and it is the most useful number in this whole category. Serum 25-hydroxyvitamin D rises predictably with extended oral cholecalciferol, and the slope is shallow — the classic estimate from controlled dosing is on the order of 1 ng/mL of serum 25(OH)D for each 100 IU/day, reached only after 8 to 12 weeks of steady intake Heaney 2003. Do the arithmetic before you buy. A foundation product carrying 1,000 IU moves a person from about 20 ng/mL to about 30. One carrying 400 IU — still common in a one-a-day — moves them to about 24, and leaves them where they started in the eyes of anyone using 30 as a threshold.

And then the outcome trial, which is the disappointment this category is built on top of. VITAL randomized 25,871 adults to 2,000 IU of vitamin D daily and followed them 5.3 years: no reduction in invasive cancer, no reduction in major cardiovascular events Manson 2019. Note the dose. 2,000 IU is at or above what most foundation bundles carry, and at that dose the answer was no. A product delivering half of it is not delivering half a benefit; it is delivering an unmeasured fraction of an effect that was not detected at twice the dose.

The multivitamin itself has one large randomized trial and it is worth reading precisely. The Physicians' Health Study II gave 14,641 male physicians a daily multivitamin for over a decade Gaziano 2012. Total cancer incidence was modestly lower. Site- specific cancers, cardiovascular events and mortality were not. So the fair summary is a small signal on a broad composite in well-nourished older physicians, which is not the same claim as covers your bases and is a great deal more than most competitors can point to.

The obstacle that applies to every trial above. All of them enrolled people who were, by and large, not deficient. That answers the question does topping up a full tank help and leaves untouched the question this product is actually bought to answer, which is is my tank empty. Those are different experiments with different expected answers, and the second one has never been run on a bundle. It can, however, be run on you, for the price of a baseline draw.

Foundation Bundle — which form, and does it matter

Vitamin D3, not D2. Cholecalciferol raises and sustains serum 25(OH)D more effectively than ergocalciferol at equal IU, largely because D2's metabolites clear faster and bind the carrier protein less avidly. The dosing data above is D3 data Heaney 2003.

Magnesium, where the label is doing two things to you at once. A survey of US commercial magnesium preparations found wide differences in absorption between salts, with the oxide the poorest performer Firoz 2001. Magnesium oxide is also the cheapest and the densest, which is why it dominates one-a-day formulas: it lets a small tablet print a large number. Then the second trick, which is not a trick so much as an arithmetic most people never do — the milligrams on the front are usually the salt, and the elemental magnesium is a fraction of it. Magnesium oxide runs about 60% elemental by weight; magnesium bisglycinate runs about 14%. A 500 mg glycinate capsule is 70 mg of magnesium. Do that subtraction on every mineral in the box.

Folate, B12 and vitamin E, in one paragraph because the pattern is the same. Folate as [6S]-5-methyltetrahydrofolate skips two conversion steps that folic acid needs. B12 as methyl- or hydroxocobalamin skips one that cyanocobalamin needs. Vitamin E as d-alpha-tocopherol is the natural RRR stereoisomer; the synthetic dl- form is a mixture of eight stereoisomers of which the body retains a minority, which is why the IU conversion differs between them. In each case the active form costs more and the trial evidence mostly belongs to the cheap one.

The %DV column is not a dose. Percent Daily Value is referenced to an intake set to prevent deficiency in almost everyone, not to the dose used in any trial on this page. 100% DV of vitamin D is 800 IU. VITAL used 2,000 and found nothing Manson 2019. A label showing a tidy column of 100% figures has told you the product is nutritionally complete and told you nothing about whether it carries a studied dose of anything.

What would have to be true, and how you would know it was not

A foundation product makes exactly one falsifiable claim — that it closes gaps — so every prediction here is about a gap.

1. 25-hydroxyvitamin D rises by about 1 ng/mL per 100 IU/day, and not before 12 weeks. Draw it first. Take the IU off the label, divide by 100, add it to your baseline, and that is the number the retest should show Heaney 2003. This is the one prediction in the Stacks category precise enough to be wrong by a specific amount, and if your retest lands well below it, the likeliest explanations are a fat-free dosing schedule, obesity sequestering the vitamin in adipose tissue, or a product that does not contain what it says.

2. RBC folate and B12 move only if they were low. Retest RBC folate at 16 weeks rather than 4, because the red cell population turns over across about 120 days and an early draw is mostly the old cells.

3. Ferritin does not move unless there is iron in the box — and if there is, that is a finding rather than a feature. Check the panel. A man or a postmenopausal woman taking iron he or she does not need is the single most common way a daily foundation product does harm rather than nothing.

4. The prediction that argues against buying it: if your baseline draw is normal, nothing measurable will change. ApoB, hs-CRP, HbA1c and fasting glucose should all be flat at six months, and on the evidence above that is the expected result rather than a failure Manson 2019 Gaziano 2012. A person with a 25(OH)D of 38 ng/mL, a normal RBC folate and a normal B12 is buying insurance against a risk they have already measured themselves out of. The draw costs less than four months of the subscription, and it is the only thing on this page that can tell you whether the product has anything to do.

What nobody has tested yet

The trial that would actually be informative has never been run because it is the opposite of how supplements are studied. Every large multivitamin trial recruits on age or convenience and then reports that a replete population did not benefit Gaziano 2012. Invert it: screen adults, enroll only those with a measured deficit — 25(OH)D below 20 ng/mL, or RBC folate below the reference range, or serum B12 with a raised methylmalonic acid — and randomize them to the bundle, to the single nutrient they are short of, or to placebo, with 12-month functional endpoints. Roughly 150 per arm. That design asks whether the bundle adds anything over correcting the one gap that exists, which is the only question a foundation product's premium depends on, and it is unanswered.

Nobody has published what these bundles actually contain. The magnesium absorption work is over two decades old Firoz 2001 and there is no equivalent modern survey that assays a shelf of commercial foundation products for label accuracy, elemental content and disintegration. It is a straightforward analytical chemistry exercise, it would cost less than a small clinical trial, and its absence is why every dose statement on this page has to be written as a threshold you check rather than a fact you can rely on.

And the magnesium-gates-vitamin-D question is testable and untested. If the hydroxylases really are magnesium-limited in practice, then two groups given identical cholecalciferol — one magnesium-replete, one not — should show different 25(OH)D slopes at 12 weeks. Sixty people, two blood tests each. That single experiment would either give this bundle its first genuine synergy claim or remove one, and nobody has bothered.

Foundation Bundle — its own safety story, not its category's

The risk a foundation product owns is the risk of being second. Almost nobody takes only this. The failure mode is arithmetic across bottles, and fat-soluble vitamins are where it bites, because they accumulate rather than spilling into urine.

Preformed vitamin A is the sharpest example. The tolerable upper intake level for adults is 3,000 micrograms RAE per day of retinol, and chronic excess causes hepatotoxicity, raised intracranial pressure and, at long exposure, reduced bone mineral density; in pregnancy it is teratogenic. A multivitamin with retinyl palmitate plus a cod liver oil plus a skin formula clears that ceiling without any one label looking excessive. Beta-carotene does not carry the same risk because conversion is regulated — but it carries a different one, having increased lung cancer incidence in smokers and asbestos-exposed workers in two large randomized prevention trials.

Zinc, copper and iron compete, and the loser is copper. Zinc and iron share divalent metal transporter 1 at the enterocyte brush border, so a large dose of one reduces uptake of the other from the same meal. The chronic problem is different and worse: zinc above roughly 40 mg/day induces metallothionein in the intestinal lining, which binds copper preferentially and sheds it back into the gut. Months of that produces copper deficiency — a sideroblastic-pattern anemia, neutropenia, and a myelopathy that looks like B12 deficiency and does not always reverse. Total your zinc across the multivitamin, the immune product and the lozenges.

Biotin is the one that can put you in a resuscitation room. High-dose biotin, common in hair and nail formulas and sometimes generous in a foundation blend, interferes with streptavidin-biotin immunoassays. It can produce a falsely low troponin during a real myocardial infarction, and falsely abnormal thyroid results that look exactly like Graves' disease. Stop biotin at least 48 hours before bloodwork and tell the emergency department you take it.

Two more, briefly. Vitamin K in a bundle is not forbidden on warfarin, but it must be constant, because the dose was titrated against your habitual intake and it is the change that moves the INR. And calcium in the same tablet as iron, zinc or levothyroxine reduces the absorption of all three, which is a timing problem rather than a dose problem — separate them by two hours.

Sources read for this page

• Heaney RP, et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. The American Journal of Clinical Nutrition, 2003 · PMID 12499343
• Manson JE, et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. The New England Journal of Medicine, 2019 · PMID 30415629
• Gaziano JM, et al. Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA, 2012 · PMID 23162860
• Firoz M, Graber M. Bioavailability of US commercial magnesium preparations. Magnesium Research, 2001 · PMID 11794633

How you would know if it worked

Foundation Bundle — safety & side effects

Bloodwork to run alongside Foundation Bundle

Baseline first, then again at 8–12 weeks.

The Basics — Start Here panel covers these in one order — 4 markers, $32.40 with the discount applied.

Check results you already have → · All 103 markers A–Z

Foundation Bundle — frequently asked questions

Foundation Bundle inside a finished plan

One arm of 1 Protocol Blueprint, free to read in full.

What Foundation Bundle is used for

Foundation Bundle appears under 1 goal in the goal router.

Related Stacks & Bundles supplements

← Browse the full Supplement Vault

↑ Back to on this page